Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy

Johannsen M. ¹ , Miller K. ¹ , Weikert S.¹ , Staehler M. ² , Ohlmann C.H. ³ , Flörcken A.⁴ , Schmittel A.⁵ , Otto T. ⁶ , Bex A.⁷ , Hein P.⁸ , Grünwald V.⁹

Annals of Oncology

Oxford University Press

3

Английский

657-663

Опубликовано

22

2011

• ¹ Department of Urology|Charité-Universitätsmedizin Berlin
• ² Department of Urology|Universitätsklinikum Grosshadern
• ³ Department of Urology|Universitätsklinikum Saarland
• ⁴ Department of Hematology and Oncology|Campus Virchow-Klinikum|Charité-Universitätsmedizin Berlin
• ⁵ Department of Hematology and Oncology|Campus Benjamin Franklin|Charité-Universitätsmedizin Berlin
• ⁶ Department of Urology
• ⁷ Department of Urology|The Netherlands Cancer Institute
• ⁸ Department of Radiology|Campus Mitte|Charité-Universitätsmedizin Berlin
• ⁹ Department of Hematology|Hemostaseology and Oncology|Medical School Hannover